Accelerating FDA Approvals – It’s Faster Outside the US

Although it may seem counterintuitive, obtaining FDA approval is often expedited when the clinical trials are conducted outside the US. This process acceleration isn't about bypassing thorough checks or compromising on quality. Instead, it leverages the benefits of certain regions' clinical research ecosystems, like those of Australia and New Zealand (ANZ).

Read more